News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,764 Results
Type
Article (43830)
Company Profile (274)
Press Release (676660)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (208455)
Career Advice (2102)
Deals (35994)
Drug Delivery (101)
Drug Development (82472)
Employer Resources (174)
FDA (16805)
Job Trends (15182)
News (352645)
Policy (33534)
Tag
Academia (2718)
Accelerated approval (5)
Adcomms (21)
Allergies (88)
Alliances (51153)
ALS (102)
Alzheimer's disease (1421)
Antibody-drug conjugate (ADC) (136)
Approvals (16795)
Artificial intelligence (276)
Autoimmune disease (26)
Automation (16)
Bankruptcy (362)
Best Places to Work (11885)
BIOSECURE Act (19)
Biosimilars (109)
Biotechnology (197)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (296)
Cancer (2360)
Cardiovascular disease (183)
Career advice (1753)
Career pathing (31)
CAR-T (161)
Cell therapy (448)
Cervical cancer (21)
Clinical research (67047)
Collaboration (882)
Company closure (2)
Compensation (567)
Complete response letters (21)
COVID-19 (2671)
CRISPR (44)
C-suite (256)
Cystic fibrosis (103)
Data (2327)
Decentralized trials (2)
Denatured (20)
Depression (47)
Diabetes (279)
Diagnostics (6538)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (111)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (87910)
Editorial (39)
Employer branding (21)
Employer resources (148)
Events (115323)
Executive appointments (751)
FDA (18187)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (793)
Gene editing (117)
Generative AI (22)
Gene therapy (325)
GLP-1 (732)
Government (4578)
Grass and pollen (4)
Guidances (152)
Healthcare (19465)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (128)
Indications (29)
Infectious disease (2818)
Inflammatory bowel disease (144)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (97)
Interviews (324)
IPO (16687)
IRA (42)
Job creations (3703)
Job search strategy (1488)
Kidney cancer (11)
Labor market (43)
Layoffs (482)
Leadership (19)
Legal (8097)
Liver cancer (78)
Lung cancer (332)
Lymphoma (161)
Machine learning (9)
Management (59)
Manufacturing (331)
MASH (75)
Medical device (13958)
Medtech (13963)
Mergers & acquisitions (19875)
Metabolic disorders (716)
Multiple sclerosis (86)
NASH (16)
Neurodegenerative disease (98)
Neuropsychiatric disorders (27)
Neuroscience (1993)
NextGen: Class of 2025 (6781)
Non-profit (4615)
Now hiring (40)
Obesity (377)
Opinion (214)
Ovarian cancer (81)
Pain (97)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (21)
Patents (243)
Patient recruitment (116)
Peanut (48)
People (58501)
Pharmaceutical (66)
Pharmacy benefit managers (21)
Phase I (20952)
Phase II (29534)
Phase III (21946)
Pipeline (1362)
Policy (151)
Postmarket research (2606)
Preclinical (8986)
Press Release (69)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (250)
Rare diseases (394)
Real estate (6054)
Recruiting (66)
Regulatory (23031)
Reports (47)
Research institute (2449)
Resumes & cover letters (366)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (72)
Series A (137)
Series B (93)
Service/supplier (12)
Sickle cell disease (52)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3698)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (31)
Vaccines (728)
Venture capitalists (42)
Weight loss (243)
Women's health (36)
Worklife (16)
Date
Today (36)
Last 7 days (948)
Last 30 days (3016)
Last 365 days (32886)
2025 (11891)
2024 (35802)
2023 (40808)
2022 (51979)
2021 (56631)
2020 (55200)
2019 (47979)
2018 (36147)
2017 (33123)
2016 (32603)
2015 (38726)
2014 (32437)
2013 (27611)
2012 (29799)
2011 (30434)
2010 (28430)
Location
Africa (762)
Alabama (54)
Alaska (7)
Arizona (236)
Arkansas (13)
Asia (39532)
Australia (6462)
California (6442)
Canada (2071)
China (543)
Colorado (276)
Connecticut (293)
Delaware (156)
Europe (86144)
Florida (953)
Georgia (219)
Idaho (61)
Illinois (557)
India (26)
Indiana (320)
Iowa (11)
Japan (173)
Kansas (108)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (936)
Massachusetts (4807)
Michigan (223)
Minnesota (413)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (25)
Nevada (67)
New Hampshire (66)
New Jersey (1801)
New Mexico (29)
New York (1821)
North Carolina (1006)
North Dakota (8)
Northern California (2830)
Ohio (212)
Oklahoma (14)
Oregon (36)
Pennsylvania (1430)
Puerto Rico (13)
Rhode Island (33)
South America (1148)
South Carolina (25)
South Dakota (1)
Southern California (2423)
Tennessee (106)
Texas (950)
United States (24209)
Utah (190)
Virginia (155)
Washington D.C. (65)
Washington State (577)
West Virginia (3)
Wisconsin (56)
720,764 Results for "ebr systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
EBR Systems’ Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results Lead to Early Trial Halt for Success
EBR Systems, Inc. (ASX: EBR), the medical device company developing wireless cardiac pacing systems, has met its primary safety and efficacy endpoints in its pivotal SOLVE-CRT trial of the WiSE® Cardiac Resynchronization Therapy (CRT) System.
May 22, 2023
·
8 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 30, 2025
·
1 min read
Press Releases
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
May 5, 2025
·
13 min read
Press Releases
FDA Approves WiSE® System, World’s First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT
April 17, 2025
·
3 min read
Press Releases
CereVasc, Inc. Receives FDA Breakthrough Device Designation for the eShunt® System for Use in Pediatric Patients
April 23, 2025
·
4 min read
Press Releases
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
·
5 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Tivic Health Systems, Inc. Announces Reverse Stock Split
March 5, 2025
·
6 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
April 1, 2025
·
1 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
March 6, 2025
·
1 min read
1 of 72,077
Next
